WO2012081898A3 - 위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법 - Google Patents

위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법 Download PDF

Info

Publication number
WO2012081898A3
WO2012081898A3 PCT/KR2011/009603 KR2011009603W WO2012081898A3 WO 2012081898 A3 WO2012081898 A3 WO 2012081898A3 KR 2011009603 W KR2011009603 W KR 2011009603W WO 2012081898 A3 WO2012081898 A3 WO 2012081898A3
Authority
WO
WIPO (PCT)
Prior art keywords
stomach cancer
predicting
prognosis
cancer prognosis
marker
Prior art date
Application number
PCT/KR2011/009603
Other languages
English (en)
French (fr)
Other versions
WO2012081898A2 (ko
Inventor
백순명
김성
강원기
이지연
배재문
손태성
노재형
최민규
박영석
박준오
박세훈
임호영
정신호
Original Assignee
사회복지법인 삼성생명공익재단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사회복지법인 삼성생명공익재단 filed Critical 사회복지법인 삼성생명공익재단
Priority to PL11849123T priority Critical patent/PL2653546T3/pl
Priority to EP11849123.2A priority patent/EP2653546B1/en
Priority to US13/994,072 priority patent/US9315869B2/en
Priority to ES11849123.2T priority patent/ES2689958T3/es
Priority to CN201180065578.XA priority patent/CN103459597B/zh
Publication of WO2012081898A2 publication Critical patent/WO2012081898A2/ko
Publication of WO2012081898A3 publication Critical patent/WO2012081898A3/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10—Complex mathematical operations
    • G06F17/18—Complex mathematical operations for evaluating statistical data, e.g. average values, frequency distributions, probability functions, regression analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Data Mining & Analysis (AREA)
  • Mathematical Physics (AREA)
  • Pure & Applied Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Mathematical Analysis (AREA)
  • Mathematical Optimization (AREA)
  • Computational Mathematics (AREA)
  • Probability & Statistics with Applications (AREA)
  • Operations Research (AREA)
  • Algebra (AREA)

Abstract

본 발명은 위암의 예후를 예측하기 위한 마커, 이의 발현수준을 측정하는 제제를 포함하는 위암의 예후 예측용 조성물 및 키트, 및 상기 마커를 이용하여 위암의 예후를 예측하는 방법에 관한 것이다. 본 발명에 의하면, 위암의 예후를 신속하고 정확하게 예측하고, 예측된 예후에 따른 적절한 치료방향을 결정할 수 있어 위암으로 인한 사망률의 감소에 크게 기여할 수 있는 이점이 있다. 특히, 본 발명에 의하여 병기 Ib/II기 위암 환자 중 음성적 예후를 가질 것이라고 예측된 환자에 대하여 병기 III기 위암 환자를 대상으로 시술되는 치료방법을 사용함으로써 생존율 증가에 크게 기여할 수 있을 것이다.
PCT/KR2011/009603 2010-12-13 2011-12-13 위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법 WO2012081898A2 (ko)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PL11849123T PL2653546T3 (pl) 2010-12-13 2011-12-13 Marker do ustalenia rokowania raka żołądka i sposób ustalenia rokowania raka żołądka
EP11849123.2A EP2653546B1 (en) 2010-12-13 2011-12-13 Marker for predicting stomach cancer prognosis and method for predicting stomach cancer prognosis
US13/994,072 US9315869B2 (en) 2010-12-13 2011-12-13 Marker for predicting gastric cancer prognosis and method for predicting gastric cancer prognosis using the same
ES11849123.2T ES2689958T3 (es) 2010-12-13 2011-12-13 Marcador para predecir el pronóstico de cáncer de estómago y procedimiento para predecir el pronóstico de cáncer de estómago
CN201180065578.XA CN103459597B (zh) 2010-12-13 2011-12-13 用于预测胃癌预后的标记和使用该标记预测胃癌预后的方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2010-0127197 2010-12-13
KR20100127197 2010-12-13
US201161432542P 2011-01-13 2011-01-13
US61/432,542 2011-01-13

Publications (2)

Publication Number Publication Date
WO2012081898A2 WO2012081898A2 (ko) 2012-06-21
WO2012081898A3 true WO2012081898A3 (ko) 2012-10-11

Family

ID=46245217

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/009603 WO2012081898A2 (ko) 2010-12-13 2011-12-13 위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법

Country Status (7)

Country Link
US (1) US9315869B2 (ko)
EP (1) EP2653546B1 (ko)
KR (1) KR101437718B1 (ko)
CN (1) CN103459597B (ko)
ES (1) ES2689958T3 (ko)
PL (1) PL2653546T3 (ko)
WO (1) WO2012081898A2 (ko)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2870835C (en) * 2012-04-19 2020-06-16 Hon Sing LEONG Method for detecting or monitoring prostate cancer
KR101504818B1 (ko) * 2013-04-05 2015-03-24 연세대학교 산학협력단 위암에 대한 예후 예측 시스템
KR101504817B1 (ko) * 2013-04-05 2015-03-24 연세대학교 산학협력단 국소 진행형 위암에 대한 예후 예측 시스템
KR101501826B1 (ko) * 2013-04-05 2015-03-13 연세대학교 산학협력단 위암에 대한 예후 예측 모형의 제조방법
CN105624279A (zh) * 2015-01-22 2016-06-01 香港中文大学深圳研究院 胃癌标记物、其表达和甲基化检测方法、试剂盒及应用
US11081225B2 (en) * 2015-03-30 2021-08-03 The Trustees Of The University Of Pennsylvania System and method for virtual radiation therapy quality assurance
CN105483226B (zh) * 2015-12-21 2018-06-19 中国人民解放军第三军医大学第三附属医院 一种检测strap基因转录水平的方法及试剂盒
KR101906657B1 (ko) 2015-12-31 2018-10-10 아주대학교산학협력단 위암 예후 예측용 바이오 마커 조성물
WO2017210662A1 (en) * 2016-06-03 2017-12-07 Castle Biosciences, Inc. Methods for predicting risk of recurrence and/or metastasis in soft tissue sarcoma
CN105986034A (zh) * 2016-06-15 2016-10-05 南京卡迪睿伯生物技术有限公司 一组胃癌基因的应用
KR101941054B1 (ko) * 2016-07-20 2019-01-23 연세대학교 산학협력단 암 예후 예측을 위한 조성물 및 이를 포함하는 키트
CN106399534A (zh) * 2016-10-20 2017-02-15 上海厚承医学科技有限公司 用于肿瘤早期筛查的肿瘤血小板rna定量检测模型及方法
JP6864089B2 (ja) 2017-03-14 2021-04-21 ノヴォミクス・カンパニー・リミテッド 進行性胃癌患者の手術後の予後または抗癌剤適合性予測システム
KR101940657B1 (ko) 2017-04-24 2019-01-21 (주) 노보믹스 위암의 생물학적 특성에 기반한 군 구분 및 예후 예측 시스템
CN107385100B (zh) * 2017-09-13 2020-03-17 成都望路医药技术有限公司 Mcm8作为胃腺癌转移标志物的用途
CN107641653B (zh) * 2017-10-20 2021-02-19 南方医科大学南方医院 Macc1-as1探针在制备用于预测胃癌临床预后的诊断试剂中的应用
WO2019129144A1 (zh) * 2017-12-27 2019-07-04 立森印迹诊断技术有限公司 一种用于检测食道肿瘤和/或胃肿瘤良恶性程度的分级模型及其应用
CN108272829A (zh) * 2018-02-14 2018-07-13 南方医科大学南方医院 Pitpnc1在制备治疗胃癌的药物中的应用
KR102129066B1 (ko) * 2018-04-11 2020-07-15 한국과학기술연구원 항암 보조치료법의 선택을 위한 혈액 마커 및 이를 이용한 치료법 선택의 방법
CN109112214A (zh) * 2018-07-27 2019-01-01 复旦大学附属中山医院 模式识别受体trem2在肝癌预后和治疗中的应用
CN109706243A (zh) * 2018-12-18 2019-05-03 南通大学附属医院 Dpp9基因在制备治疗胃癌药物及其诊断试剂盒中的应用
CN109576373A (zh) * 2019-01-02 2019-04-05 首都医科大学附属北京朝阳医院 circ-VAPA作为胃癌和结直肠癌诊断生物标志物和治疗靶点的应用
JP7232922B2 (ja) * 2019-01-17 2023-03-03 ジーニナス インコーポレイテッド 抗癌剤反応性予測用バイオマーカーおよびその用途
CN109902421A (zh) * 2019-03-08 2019-06-18 山东大学齐鲁医院 一种宫颈癌预后评估方法、系统、存储介质及计算机设备
KR102168304B1 (ko) * 2019-08-07 2020-10-21 한림대학교 산학협력단 인공호흡 삽관 환자의 nox4 농도 측정으로 탈관 예후 또는 28일 사망률을 예측하는 방법
CN110656178A (zh) * 2019-10-28 2020-01-07 上海交通大学 胃癌预后诊断标志物trem1的应用及检测试剂盒
CN111323604B (zh) * 2020-04-14 2023-04-07 郑州大学第一附属医院 一组贲门腺癌预后预测标志物及其应用
CN111735946B (zh) * 2020-05-22 2023-07-07 首都医科大学附属北京友谊医院 血清aldh1b1自身抗体定量检测试剂盒及其应用
CN111739641A (zh) * 2020-06-23 2020-10-02 杭州和壹医学检验所有限公司 一种胃癌风险预测方法、系统、计算机设备及可读存储介质
CN112133369B (zh) * 2020-08-26 2023-09-22 吴安华 基于活性氧评估肿瘤患者预后性的系统以及药物敏感性评价与改善方法
CN112280857B (zh) * 2020-10-19 2022-07-08 郑州大学 一种用于肝细胞癌诊断的生物标志物及其应用
WO2022193097A1 (zh) * 2021-03-15 2022-09-22 杭州诺辉健康科技有限公司 用于肝癌早筛的核酸及蛋白检测靶标组合及其联合检测方法
CN113462773A (zh) * 2021-05-19 2021-10-01 山东大学 一种预测胃癌患者生存风险、免疫治疗响应和细胞焦亡诱导剂适用性的标志物及其应用
CN113555121B (zh) * 2021-08-25 2024-05-28 南方医科大学南方医院 一种胃癌预后标志物的筛选和分类方法、胃癌预后标志物和检测胃癌预后的试剂及应用
CN113604576B (zh) * 2021-10-09 2022-01-07 上海晟燃生物科技有限公司 肺腺癌检测试剂盒、存储介质及电子设备
CN113774142A (zh) * 2021-10-11 2021-12-10 北京化工大学 Tgr5在制备治疗肠癌药物及诊断性试剂盒中的应用
CN114107509B (zh) * 2021-12-09 2023-06-09 江苏省肿瘤医院 一种肝癌预后标记物及其应用
CN114934116A (zh) * 2022-01-28 2022-08-23 中国医学科学院北京协和医院 早期胃癌预后差异基因与复发预测模型
CN114814023A (zh) * 2022-04-24 2022-07-29 江苏省中医院 脂质分子在作为胃癌化疗药耐药的预测性标志物中的应用
CN114705859B (zh) * 2022-04-26 2023-02-24 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种用于肝癌骨转移诊断、治疗和预后的生物标志物及其应用
KR102560831B1 (ko) * 2022-05-31 2023-08-02 서울대학교병원 위암 발병 가능성 예측을 위한 바이오마커 및 이의 용도
CN115466793B (zh) * 2022-09-26 2023-09-01 山东大学 Acot9基因的检测试剂在制备胃癌检测试剂盒中的应用及胃癌检测试剂盒
CN116064806B (zh) * 2022-10-19 2023-09-22 常州国药医学检验实验室有限公司 一种评估早期胃癌淋巴结转移风险的组合物及其用途
CN116106549A (zh) * 2023-02-20 2023-05-12 山东大学齐鲁医院 生物标志物在制备预测胆管癌预后产品中的应用
CN116500268B (zh) * 2023-04-23 2024-04-09 武汉大学人民医院（湖北省人民医院） 与骨肉瘤相关的hox基因的用途
CN117757947A (zh) * 2024-02-21 2024-03-26 上海金翌生物科技有限公司 用于检测膀胱癌生物标志物甲基化水平的引物组、探针组、试剂盒及方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050119210A1 (en) 2003-05-20 2005-06-02 Xiaobing Be Compositions and methods for diagnosing and treating cancers
CN101068936A (zh) 2004-11-22 2007-11-07 惠氏公司 用于实体瘤预后及治疗的方法和系统
TWI359198B (en) * 2005-08-30 2012-03-01 Univ Nat Taiwan Gene expression profile predicts patient survival
BRPI0618597A2 (pt) 2005-11-14 2011-09-06 Bayer Healthcare Llc métodos de predição e prognóstico de cáncer e método de monitoramento de terapia contra o cáncer
KR101416475B1 (ko) 2006-02-27 2014-07-16 사회복지법인 삼성생명공익재단 암진단용 마커 단백질, 그리고 이를 이용한 암진단방법 및암 진단키트
WO2009147656A1 (en) * 2008-06-01 2009-12-10 Rosetta Genomics Ltd. Compositions and methods for prognosis of gastric cancer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHO, Y. E. ET AL.: "Expression and prognostic significance of human growth and transformation-dependent protein in gastric carcinoma and gastric adenoma", HUMAN PATHOLOGY., vol. 40, no. 7, 9 March 2009 (2009-03-09), pages 975 - 981, XP026168733 *
CHU, D. ET AL.: "Matrix metalloproteinase-9 as associated with disease-free survival and overall survival in patients with gastric cancer", INTERNATIONAL JOURNAL OF CANCER., vol. 129, no. 4, 8 December 2010 (2010-12-08), pages 887 - 895, XP055108854 *
TAKENO, A. ET AL.: "Gene expression profile prospectively predicts peritoneal relapse after curative surgery of gastric cancer", ANNALS OF SURGICAL ONCOLOGY., vol. 17, no. 4, 11 December 2009 (2009-12-11), pages 1033 - 1042, XP019785929 *
XU, Z. Y. ET AL.: "Gene expression profile towards the prediction of patient survival of gastric cancer", BIOMEDICINE AND PHARMACOTHERAPY., vol. 64, no. 2, 13 November 2009 (2009-11-13), pages 133 - 139, XP026908291 *

Also Published As

Publication number Publication date
ES2689958T3 (es) 2018-11-16
CN103459597B (zh) 2016-03-30
EP2653546A4 (en) 2016-11-09
EP2653546A2 (en) 2013-10-23
US9315869B2 (en) 2016-04-19
US20130337449A1 (en) 2013-12-19
KR101437718B1 (ko) 2014-09-11
KR20120065959A (ko) 2012-06-21
EP2653546B1 (en) 2018-08-08
PL2653546T3 (pl) 2019-06-28
WO2012081898A2 (ko) 2012-06-21
CN103459597A (zh) 2013-12-18

Similar Documents

Publication Publication Date Title
WO2012081898A3 (ko) 위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법
MX366925B (es) Inhibidores de ibat para el tratamiento de enfermedades hepaticas.
MX356671B (es) Métodos para inhibir fucosilación de proteína in vivo utilizando análogos de fucosa.
MX353482B (es) Metodos para el tratamiento del cancer y enfermedades inflamatorias utilizando cereblon como predictor.
WO2010102195A3 (en) Annexin a11 and associated genes as biomarkers for cancer
WO2010062863A3 (en) Compositions containing satiogens and methods of use
MX2013010343A (es) Composicion y metodos para el transplante de microbiota de colon.
MY195289A (en) Anti IL-36R Antibodies
WO2012068383A3 (en) ncRNA AND USES THEREOF
IN2014MN02089A (ko)
CA2837341C (en) Method of determining vasoreactivity using inhaled nitric oxide
WO2012078667A3 (en) Compositions and methods relating to proliferative diseases
WO2012078546A3 (en) Compositions and methods for stabilizing ingredients using 2,4-pentanedione compounds
GEP20125647B (en) Kinesin inhibitors as cancer therapeutics
MX2013000958A (es) Fabricación del inhibidor-inter-alfa (iaip) a partir de plasma.
WO2011153234A3 (en) Methods of inhibiting alu rna and therapeutic uses thereof
MX2012007898A (es) Metodos para proveer terapia de perdida de peso en pacientes con depresion mayor.
WO2012014083A3 (en) Frataxin mutants
EP3495502A3 (en) Biomarkers for premature birth
WO2012106427A3 (en) Methods for treating diabetic foot ulcers
WO2011163566A3 (en) Methods of treating patients with immune-related diseases
WO2013040251A3 (en) Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
WO2014140362A3 (en) Lymphocyte biomarkers for determining the clinical response to therapy with mesenschymal stromal cells(msc)
AU2010286532A8 (en) Methods of treatment using anti-oxidized LDL antibodies
SG195127A1 (en) Methods of treating or preventing neurological diseases

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180065578.X

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11849123

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2011849123

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 13994072

Country of ref document: US